about
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI.Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome.Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome.A widespread picture of the Streptococcus thermophilus proteome by cell lysate fractionation and gel-based/gel-free approaches.Expression of adenylate kinase 1 in bovine retinal cytosol.High-resolution 2-DE for resolving proteins, protein adducts and complexes in plasma.Proteomic analysis of the retinal rod outer segment disks.Live imaging of mammalian retina: rod outer segments are stained by conventional mitochondrial dyes.En bloc elution of proteomes from combinatorial peptide ligand libraries.Combinatorial peptide ligand libraries for urine proteome analysis: investigation of different elution systems.Evidence for aerobic metabolism in retinal rod outer segment disks.Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens.'Proteomineering': has the mine been excavated?"Cheek-to-cheek" urinary proteome profiling via combinatorial peptide ligand libraries: A novel, unexpected elution system.Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.Mark Twain: how to fathom the depth of your pet proteome.Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis.Combinatorial ligand libraries as a two-dimensional method for proteome analysis.Combinatorial peptide ligand libraries as a "Trojan Horse" in deep discovery proteomics.From hundreds to thousands: Widening the normal human Urinome (1).Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens.Combinatorial Peptide Ligand Library and two dimensional electrophoresis: new frontiers in the study of peritoneal dialysis effluent in pediatric patients.Widening and diversifying the proteome capture by combinatorial peptide ligand libraries via Alcian Blue dye binding.Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference.From hundreds to thousands: Widening the normal human UrinomeCoexistence of different circulating anti-podocyte antibodies in membranous nephropathy.Reaction of 2-amino-2-deoxy-D-glucose and lysine: isolation and characterization of 2,5-bis(tetrahydroxybutyl)pyrazine.The oxido-redox potential of albumin methodological approach and relevance to human diseases.2D-electrophoresis and the urine proteome map: where do we stand?Analysis of the oxido-redox status of plasma proteins. Technology advances for clinical applications.In vivo characterization of renal auto-antigens involved in human auto-immune diseases: the case of membranous glomerulonephritis.Proteomics unravels the exportability of mitochondrial respiratory chains.Recent advances in electrophoretic techniques for the characterization of protein biomolecules: a poker of aces.Urinary proteome in a snapshot: normal urine and glomerulonephritis.Oxidized albumin. The long way of a protein of uncertain function.Albumin heterogeneity in low-abundance fluids. The case of urine and cerebro-spinal fluid.Human urinary exosome proteome unveils its aerobic respiratory ability.Urine proteome analysis in Dent's disease shows high selective changes potentially involved in chronic renal damage.
P50
Q30596600-0C8E0F43-0B29-4FA0-B0A7-325849A92254Q33220376-2590ADFC-FDE8-4F1F-8F39-D2138C7DF78DQ33258651-B3F3C673-AAF9-4D96-9E5F-963FA2714BF3Q33281037-3D1859A1-B467-40D0-A786-26EE11C698B0Q33282563-EF2C587B-20E4-4EDF-959F-88F495BDAD75Q33314116-A5EAAC27-7E02-457F-819D-FCA106F58C7DQ33335847-3951B858-433C-4310-B63F-075B801ECC68Q33385792-F0DC63FB-66DE-4AC9-94A9-FF612F94F453Q33415851-CB9A9F74-8104-416A-A851-E16D6BC64449Q33481063-218A4FE3-DFB4-4BD2-9112-BD3DAE58FD11Q33498189-73730AED-0747-4EA2-A7D0-F84FEFABFDF4Q33530824-6E7841D0-D857-4333-97CC-ED031CE3A8FDQ33566081-E3A1FA6B-0C4E-4D28-B054-0A422B1D8215Q33922405-96840543-1DEF-4A84-B79D-D4D22C8D1C54Q33983841-B0BC8362-CFAF-4FB5-B780-E72698707D1BQ34044233-FCA704FB-825D-4876-9F68-00920BD816BBQ34136009-D0C230A2-DFF3-412B-AB96-A9C0A32E791BQ34296475-05DD65A2-A397-4656-B599-F07B2D46F058Q34324172-D1C5B0B0-7D12-464C-90C0-18E668342988Q34751431-A46D3DE5-085A-41FE-8D34-D8AACBF1BFC9Q35217179-E924C9D2-50F6-4F76-AED5-5D6F8834B63AQ35225054-AE7A6C8F-604F-4369-8153-B15B7ED19077Q35422370-82DDDD4B-50AF-4390-9369-5178001CC508Q35542200-73D786AD-2D2B-4B76-9447-296EA42FE6DBQ35598053-4C2422AD-426D-42E4-AEF8-BDDC7107EED6Q35608355-F3166D63-A961-4A14-96E8-5DD1A2B040E2Q35718785-AAB3928F-EF60-4644-9EC8-1E254005A465Q36199508-F32E08A8-FFC0-4097-88DE-50E9688FF201Q36434686-AC354758-598D-4E30-8DBE-7E8A0407E739Q37525423-EC7C022B-6181-41ED-A4AA-D7DC963E1690Q37652060-E6FF98C5-9BB6-4E6C-94D1-2AC08FFD5CF3Q37824013-31C7D300-EDBB-4BBC-A052-FD11D6B38763Q37830008-DEDE0706-4100-4152-8EC3-E0B1DFE8E96FQ37866313-7E9BD38A-6108-4DAC-AD6C-95C862BD54E3Q37871165-458FBE84-6BE9-4534-A3F0-8BA6DFD7B447Q38052115-02742F6A-6149-4FE4-B405-26148BA569B6Q38101749-4BEEB4ED-F6D8-4DBA-B4B2-F478B2CCDE34Q38102865-86B8BC81-2960-42B0-9BD9-995E70F6D919Q38451324-CCF05036-A661-4A4E-A8FA-3598151107B3Q38457820-02B317A7-7EEC-4965-94FE-B8438EDE4AD0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giovanni Candiano
@ast
Giovanni Candiano
@en
Giovanni Candiano
@es
Giovanni Candiano
@nl
Giovanni Candiano
@sl
type
label
Giovanni Candiano
@ast
Giovanni Candiano
@en
Giovanni Candiano
@es
Giovanni Candiano
@nl
Giovanni Candiano
@sl
prefLabel
Giovanni Candiano
@ast
Giovanni Candiano
@en
Giovanni Candiano
@es
Giovanni Candiano
@nl
Giovanni Candiano
@sl
P1053
J-9357-2018
P106
P1153
7004556744
P21
P31
P3829
P496
0000-0002-7385-2787